| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.7 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |